TAMPA, FLORIDA – September 30, 2021 – HealthEdge Investment Partners (“HealthEdge”) announced today that it has exited the majority of its investment in Fund II portfolio company Formulated Solutions, LLC (“Formulated” or the “Company”) to Linden Capital Partners (“Linden”). HealthEdge generated an exceptional return on its minority investment following strong organic growth at Formulated and retained an ongoing stake in the Company.

Headquartered in Largo, FL, Formulated Solutions provides contract development and manufacturing services for over-the-counter (“OTC”) and prescription (“Rx”) healthcare products, with a focus on complex topical and nasal formulations in semi-solid, aerosol, and liquid formats. 

Brian Anderson, HealthEdge Managing Partner, said “The transaction is a rewarding validation of our investment thesis on Formulated Solutions and the CDMO market.  At the time of our investment, we believed Formulated Solutions was poised for growth given its manufacturing capabilities, niche expertise, customer list, robust pipeline, and senior management team.  Under strong leadership, the Company executed its plan to expand capacity, add innovation, formulation and manufacturing capabilities, and has far surpassed our growth objectives.  We are proud to have partnered with Formulated Solutions and Eric Dann to support the Company through our investment and look forward to the future expansion of the Company through the new partnership with Linden.”  

ABOUT HEALTHEDGE

HealthEdge Investment Partners, LLC is an operating-oriented private equity firm founded in 2005 that focuses exclusively on the healthcare industry. HealthEdge seeks to achieve superior returns by investing in businesses that benefit from the knowledge, experience, and network of relationships of its partners. HealthEdge’s partners have more than 100 years of combined operating experience in healthcare as CEOs and investors. For more information on HealthEdge, please visit healthedgepartners.com.

ABOUT FORMULATED SOLUTIONS

Founded in 1999, Formulated Solutions has long been known as one of the most innovative contract manufacturing and formulation development companies (CDMO) in North America. With over 650 million units of annualized production capacity, Formulated Solutions exists to enhance consumer healthcare products through creativity and invention, delivering our Marketing Partners unmatched formulations, innovative packaging, and cost-effective reliable supply of semisolids, aerosols, and Bag on Valve products. With partnerships with seven of the world's top 12 Consumer Healthcare companies, the regulated products we've developed and the brands we support cover a global footprint of more than 45 countries, supported by numerous regulatory body registrations, including FDA, ANVISA, EMA, Health Canada, TGA, Korean Ministry of Food and Drug Safety, UL, ISO and more.

ABOUT LINDEN CAPITAL PARTNERS

Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the country’s largest dedicated healthcare private equity firms. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating experience, and (iii) its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested more than $2.5 billion in healthcare companies. For more information, please visit www.lindenllc.com.